Actuate Therapeutics, Inc. (NASDAQ:ACTU) IPO

Actuate Therapeutics, Inc.

IPO

Priced at US$8.00 a share on Aug 12, 2024.

Price
US$8.00 a share
Shares offered
2,800,000 shares of common stock
Offering size
US$22.4 million
Underwriters' option
Up to 420,000 more shares
Listing
ACTU on the Nasdaq Global Market
Underwriters
Titan Partners Group, Newbridge Securities Corporation · In the order on the cover
Shares delivered
On or about Aug 14, 2024

Steps

StepWhen
Draft sent to the SEC in confidenceMar 4, 2024
Filed publiclyMay 24, 2024
Amended 5 timesNewest Jul 23, 2024
Shares registered with an exchangeJun 20, 2024
Declared effective by the SECAug 12, 2024
Final prospectus, with the priceAug 13, 2024

Filings

FilingFiled
424B4 · ProspectusAug 13, 2024
EFFECT · Notice that a registration is effectiveAug 12, 2024
CERT · Exchange's certificate of listingAug 12, 2024
CORRESP · Letter to the SECAug 12, 2024
CORRESP · Letter to the SECAug 12, 2024
8-A12B/A · Registration of shares for listing on an exchange, amendedAug 12, 2024
CORRESP · Letter to the SECAug 2, 2024
CORRESP · Letter to the SECAug 2, 2024
CORRESP · Letter to the SECJul 30, 2024
CORRESP · Letter to the SECJul 30, 2024
CORRESP · Letter to the SECJul 26, 2024
CORRESP · Letter to the SECJul 26, 2024
FWP · Free writing prospectusJul 23, 2024
S-1/A · Registration statement, amendedJul 23, 2024
CORRESP · Letter to the SECJul 19, 2024
CORRESP · Letter to the SECJul 19, 2024
FWP · Free writing prospectusJul 19, 2024
S-1/A · Registration statement, amendedJul 19, 2024
CORRESP · Letter to the SECJul 17, 2024
CORRESP · Letter to the SECJul 17, 2024
S-1/A · Registration statement, amendedJul 16, 2024
CORRESP · Letter to the SECJul 15, 2024
CORRESP · Letter to the SECJul 15, 2024
FWP · Free writing prospectusJun 21, 2024
CORRESP · Letter to the SECJun 21, 2024
S-1/A · Registration statement, amendedJun 21, 2024
8-A12B · Registration of shares for listing on an exchangeJun 20, 2024
UPLOAD · Letter from the SECJun 18, 2024
FWP · Free writing prospectusJun 11, 2024
S-1/A · Registration statement, amendedJun 11, 2024
CORRESP · Letter to the SECJun 11, 2024
UPLOAD · Letter from the SECMay 31, 2024
CORRESP · Letter to the SECMay 24, 2024
S-1 · Registration statementMay 24, 2024
UPLOAD · Letter from the SECMay 20, 2024
DRS/A · Draft registration statement, amendedMay 13, 2024
DRSLTR · Letter to the SEC with a draftMay 10, 2024
UPLOAD · Letter from the SECMay 8, 2024
DRSLTR · Letter to the SEC with a draftApr 30, 2024
DRS/A · Draft registration statement, amendedApr 30, 2024
UPLOAD · Letter from the SECApr 19, 2024
DRSLTR · Letter to the SEC with a draftApr 9, 2024
DRS/A · Draft registration statement, amendedApr 9, 2024
UPLOAD · Letter from the SECApr 1, 2024
DRSLTR · Letter to the SEC with a draftMar 4, 2024
DRS · Draft registration statementMar 4, 2024

From the cover of the final prospectus (424B4) filed Aug 13, 2024